VEGFA and neoplasm: It is likely that the reduced levels of survival signalling pathways activated by RT in P529-treated mice (i.e., Akt, VEGF, Id-1, and MMPs) end up in a reduced proliferation/apoptosis ratio in vivo, leading to tumour shrinkage.